Hepacivirus

"Hepacivirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.

Descriptor ID	D016174
MeSH Number(s)	B04.450.410 B04.820.250.475
Concept/Terms	Hepacivirus Hepacivirus Hepaciviruses Hepatitis C-Like Viruses Hepatitis C Like Viruses Hepatitis C-Like Virus Hepatitis C virus Hepatitis C virus Hepatitis C viruses

Below are MeSH descriptors whose meaning is more general than "Hepacivirus".

Organisms [B]
Viruses [B04]
Hepatitis Viruses [B04.450]
Hepacivirus [B04.450.410]
RNA Viruses [B04.820]
Flaviviridae [B04.820.250]
Hepacivirus [B04.820.250.475]

Below are MeSH descriptors whose meaning is related to "Hepacivirus".

Below are MeSH descriptors whose meaning is more specific than "Hepacivirus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepacivirus" by people in this website by year, and whether "Hepacivirus" was a major or minor topic of these publications.

Bar chart showing 43 publications over 23 distinct years, with a maximum of 4 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1998	0	1	1
1999	0	1	1
2001	1	0	1
2003	2	0	2
2004	1	0	1
2006	2	2	4
2007	1	0	1
2008	2	0	2
2009	2	0	2
2010	1	1	2
2011	0	3	3
2012	2	0	2
2013	1	2	3
2016	2	0	2
2017	1	0	1
2018	2	0	2
2019	1	0	1
2020	1	1	2
2021	2	0	2
2022	0	3	3
2023	0	3	3
2024	0	1	1

Below are the most recent publications written about "Hepacivirus" by people in Profiles.

Hage K, Boyd A, Op de Coul ELM, Sarink D, Hoornenborg E, Prins M. Hepatitis C virus infection is uncommon at baseline and during follow-up among individuals using PrEP in the Dutch national PrEP programme between 2019 and 2022. Sex Transm Infect. 2024 Jul 26; 100(5):288-294.

View in: PubMed
Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Bairey Merz CN, Jordan WC, Daar ES, Bhattacharya D, Chew KW. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation. AIDS. 2024 03 01; 38(3):317-327.

View in: PubMed
Col?n-L?pez V, Alvelo-Fern?ndez PM, Centeno-Alvarado N, Agudelo Salas IY, Rol?n Col?n Y, Pab?n Mart?nez M, Rodr?guez-Lebr?n JL, Reyes-Pulliza JC. Seroprevalence and risk factors associated with hepatitis C: a cross-sectional study of persons who inject drugs in Puerto Rico, 2018. BMC Public Health. 2023 04 18; 23(1):704.

View in: PubMed
Jacobson JM, Zahrieh D, Strand CA, Cruz-Correa M, Pungpapong S, Roberts LR, Mandrekar SJ, Rodriguez LM, Boyer J, Marrero I, Kraynyak KA, Morrow MP, Sylvester AJ, Pawlicki JM, Gillespie E, Barranco E, Richmond E, Umar A, Weiner DB, Limburg PJ. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prev Res (Phila). 2023 03 01; 16(3):163-173.

View in: PubMed
Jiang X, Diaby V, Vouri SM, Lo-Ciganic W, Parker RL, Wang W, Chang SH, Wilson DL, Henry L, Park H. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs. Am J Prev Med. 2023 01; 64(1):96-104.

View in: PubMed
Ozga JE, Syvertsen JL, Pollini RA. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California. J Viral Hepat. 2022 07; 29(7):518-528.

View in: PubMed
Shikuma CM, Le T, Phuong TV, Chew GM, Nguyen VVC, Vo TL, Siriwardhana C, Chow D, Ghukasyan H, Limpruttidham N, Premeaux T, Gangcuangco LM, Paul R, Ndhlovu LC. Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam. AIDS Res Hum Retroviruses. 2022 06; 38(6):441-450.

View in: PubMed
Islam JY, Spees L, Camacho-Rivera M, Vidot DC, Yarosh R, Wheldon CW. Disparities in Awareness of Hepatitis C Virus Among US Adults: An Analysis of the 2019 Health Information National Trends Survey. Sex Transm Dis. 2021 12 01; 48(12):981-985.

View in: PubMed
Jiang X, Parker RL, Vouri SM, Lo-Ciganic W, Diaby V, Henry L, Park H. Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders. Am J Prev Med. 2021 10; 61(4):576-584.

View in: PubMed
Liu L, Daftary MN, Alzahrani MS, Ohanele C, Maneno MK. Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C. J Natl Med Assoc. 2021 Apr; 113(2):147-157.

View in: PubMed

People

Explore

Similar Concepts

Top Journals